These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 39368772)

  • 21. Long non-coding ribonucleic acid urothelial carcinoma-associated 1 promotes high glucose-induced human retinal endothelial cells angiogenesis through regulating micro-ribonucleic acid-624-3p/vascular endothelial growth factor C.
    Yan H; Yao P; Hu K; Li X; Li H
    J Diabetes Investig; 2021 Nov; 12(11):1948-1957. PubMed ID: 34137197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of microRNAs in the modulation of diabetic retinopathy.
    Mastropasqua R; Toto L; Cipollone F; Santovito D; Carpineto P; Mastropasqua L
    Prog Retin Eye Res; 2014 Nov; 43():92-107. PubMed ID: 25128741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. tiRNA-Val promotes angiogenesis via Sirt1-Hif-1α axis in mice with diabetic retinopathy.
    Xu Y; Zou H; Ding Q; Zou Y; Tang C; Lu Y; Xu X
    Biol Res; 2022 Mar; 55(1):14. PubMed ID: 35346383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of Lnc-RNAs in the Pathogenesis and Development of Diabetic Retinopathy.
    Perisset S; Potilinski MC; Gallo JE
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular Mediators and Regulators of Retinal Angiogenesis.
    Vishwakarma S; Kaur I
    Semin Ophthalmol; 2023 Feb; 38(2):124-133. PubMed ID: 36536520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circular Noncoding RNA HIPK3 Mediates Retinal Vascular Dysfunction in Diabetes Mellitus.
    Shan K; Liu C; Liu BH; Chen X; Dong R; Liu X; Zhang YY; Liu B; Zhang SJ; Wang JJ; Zhang SH; Wu JH; Zhao C; Yan B
    Circulation; 2017 Oct; 136(17):1629-1642. PubMed ID: 28860123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of microRNAs in activating neovascularization pathways in diabetic retinopathy.
    Satari M; Aghadavod E; Mirhosseini N; Asemi Z
    J Cell Biochem; 2019 Jun; 120(6):9514-9521. PubMed ID: 30556195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Knockdown of NEAT1 exerts suppressive effects on diabetic retinopathy progression via inactivating TGF-β1 and VEGF signaling pathways.
    Shao K; Xi L; Cang Z; Chen C; Huang S
    J Cell Physiol; 2020 Dec; 235(12):9361-9369. PubMed ID: 32356340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aberrant expression of long noncoding RNAs in early diabetic retinopathy.
    Yan B; Tao ZF; Li XM; Zhang H; Yao J; Jiang Q
    Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):941-51. PubMed ID: 24436191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The ideal treatment timing for diabetic retinopathy: the molecular pathological mechanisms underlying early-stage diabetic retinopathy are a matter of concern.
    Sun WJ; An XD; Zhang YH; Zhao XF; Sun YT; Yang CQ; Kang XM; Jiang LL; Ji HY; Lian FM
    Front Endocrinol (Lausanne); 2023; 14():1270145. PubMed ID: 38027131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcriptome analysis identified a novel 3-LncRNA regulatory network of transthyretin attenuating glucose induced hRECs dysfunction in diabetic retinopathy.
    Shao J; Zhang Y; Fan G; Xin Y; Yao Y
    BMC Med Genomics; 2019 Oct; 12(1):134. PubMed ID: 31615521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological roles of lncRNAs in diabetic retinopathy with a focus on oxidative stress and inflammation.
    Chen C; Ding P; Yan W; Wang Z; Lan Y; Yan X; Li T; Han J
    Biochem Pharmacol; 2023 Aug; 214():115643. PubMed ID: 37315816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LncRNA FLG-AS1 Mitigates Diabetic Retinopathy by Regulating Retinal Epithelial Cell Inflammation, Oxidative Stress, and Apoptosis via miR-380-3p/SOCS6 Axis.
    Luo R; Li L; Xiao F; Fu J
    Inflammation; 2022 Oct; 45(5):1936-1949. PubMed ID: 35461393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of ncRNAs-mediated pyroptosis in diabetes and its vascular complications.
    Feng X; Yang X; Zhong Y; Cheng X
    Cell Biochem Funct; 2024 Mar; 42(2):e3968. PubMed ID: 38439590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Noncoding RNAs: Versatile regulators of endothelial dysfunction.
    Piao X; Ma L; Xu Q; Zhang X; Jin C
    Life Sci; 2023 Dec; 334():122246. PubMed ID: 37931743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurodegeneration in the pathogenesis of diabetic retinopathy: molecular mechanisms and therapeutic implications.
    Stem MS; Gardner TW
    Curr Med Chem; 2013; 20(26):3241-50. PubMed ID: 23745549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circular RNA-ZNF532 regulates diabetes-induced retinal pericyte degeneration and vascular dysfunction.
    Jiang Q; Liu C; Li CP; Xu SS; Yao MD; Ge HM; Sun YN; Li XM; Zhang SJ; Shan K; Liu BH; Yao J; Zhao C; Yan B
    J Clin Invest; 2020 Jul; 130(7):3833-3847. PubMed ID: 32343678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-148a-3p alleviates high glucose-induced diabetic retinopathy by targeting TGFB2 and FGF2.
    Wang J; Yao Y; Wang K; Li J; Chu T; Shen H
    Acta Diabetol; 2020 Dec; 57(12):1435-1443. PubMed ID: 32661705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic and prognostic role of serum miR-20b, miR-17-3p, HOTAIR, and MALAT1 in diabetic retinopathy.
    Shaker OG; Abdelaleem OO; Mahmoud RH; Abdelghaffar NK; Ahmed TI; Said OM; Zaki OM
    IUBMB Life; 2019 Mar; 71(3):310-320. PubMed ID: 30468285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-384-3p inhibits retinal neovascularization through targeting hexokinase 2 in mice with diabetic retinopathy.
    Xia F; Sun JJ; Jiang YQ; Li CF
    J Cell Physiol; 2018 Jan; 234(1):721-730. PubMed ID: 30191948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.